Use of TandemHeart as Bridge to Recovery for Antibody-Mediated Rejection in a Heart Transplant Patient

Juan P Rodriguez-Escudero; Antonio Duran; Clement Eiswirth; Stacy A Mandras; Sapna V Desai; Hamang M Patel; Rajan Patel; Hector O Ventura; Selim R Krim

doi:10.1016/j.jaccas.2020.11.001

Use of TandemHeart as Bridge to Recovery for Antibody-Mediated Rejection in a Heart Transplant Patient

JACC Case Rep. 2020 Dec 16;2(15):2358-2362. doi: 10.1016/j.jaccas.2020.11.001. eCollection 2020 Dec.

Authors

Juan P Rodriguez-Escudero¹, Antonio Duran¹, Clement Eiswirth¹, Stacy A Mandras^{1

2}, Sapna V Desai¹, Hamang M Patel¹, Rajan Patel^{1

2}, Hector O Ventura^{1

2}, Selim R Krim^{1

2}

Affiliations

¹ Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA.
² Department of Medicine, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana, USA.

Abstract

Antibody-mediated rejection is a major cause of graft failure, mortality, and morbidity among cardiac transplant recipients. We present the first reported case of TandemHeart (LivaNova, Pittsburgh, Pennsylvania) used in the management of antibody-mediated rejection associated with cardiogenic shock. (Level of Difficulty: Advanced.).

Keywords: AMR, antibody-mediated rejection; CS, cardiogenic shock; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon pump; LVEF, left ventricular ejection fraction; MCS, mechanical circulatory support; OHT, orthotopic heart transplantation; acute heart failure; cardiac assist devices; cardiac transplant; cardiomyopathy; hemodynamics; pAMR, pathological antibody-mediated rejection; right-sided catheterization.

Publication types

Case Reports